International Marijuana Business News

Don’t expect a major rollout of infused cannabis products in Canada until 2020

Infused cannabis products won’t be widely distributed in Canada until 2020, according to one of the leading experts in the field – but businesses shouldn’t drag their feet on preparations. Regulatory hurdles and logistical challenges will likely push distribution of most products into 2020, according to Tom Ulanowski, president of Vancouver, British Columbia-based Nextleaf Labs. Vape pens […]

Read More

Netherlands prepares legal recreational cannabis cultivation experiment

The Netherlands is laying the groundwork to become the first country in Europe to allow commercial production of adult-use marijuana – although initially the program would be considered an experiment. Under the Dutch plan, a limited number of companies would be allowed to legally grow marijuana to supply coffee shops in the country that would, […]

Read More

Cannabis firm Cronos Group misses on revenue, reports wider Q1 loss

Toronto-based Cronos Group reported first-quarter results Thursday revealing the licensed marijuana company’s losses grew from a year ago as it missed revenue expectations. Cronos reported first-quarter revenue of 6.5 million Canadian dollars ($4.8 million) for the period ended March 31 – up 120% from the year-ago period, the company said in a news release. The […]

Read More

5 key takeaways from MJBizDaily’s European Cannabis Symposium

With Europe fast becoming a cornerstone in the global medical marijuana industry, business leaders from dozens of countries descended on Copenhagen to discuss emerging opportunities in the burgeoning market. Capital markets, partnerships and more were on the docket Monday at Marijuana Business Daily’s inaugural European Cannabis Symposium in Denmark, one of the countries leading the medical […]

Read More

Net loss for cannabis firm MJardin balloons in 2018

Denver-based MJardin Group reported revenue for 2018 of 27.5 million Canadian dollars ($20.4 million), up 38% over revenue in 2017. The marijuana company recorded a net loss for 2018 of CA$84.3 million, compared with a year-ago profit of CA$1.5 million, primarily stemming from losses connected to Canadian cultivation operations. MJardin operates cultivation, processing and retail […]

Read More

Epidiolex, Sativex maker GW Pharmaceuticals reports Q1 revenue, loss improvement

United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with $3 million in the same period a year ago. The maker of cannabis-derived medications, including Sativex and Epidiolex, recorded a net loss for the quarter of $50.1 million compared with a year-ago net loss of $69.5 million. […]

Read More